Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study

被引：0
|
作者：
Sara M. Tolaney
Hovav Nechushtan
Ilan-Gil Ron
Patrick Schöffski
Ahmad Awada
Chris A. Yasenchak
A. Douglas Laird
Bridget O’Keeffe
Geoffrey I. Shapiro
Eric P. Winer
机构：
[1] Dana-Farber Cancer Institute,Department of Medical Oncology, Breast Oncology Center
[2] Brigham and Women’s Hospital,Department of Medicine
[3] Hadassah Hebrew University Medical Center,Oncology Department
[4] Tel Aviv University,Department of Oncology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine
[5] KU Leuven,Department of General Medical Oncology, Leuven Cancer Institute
[6] Universite Libre de Bruxelles,Medical Oncology, Institut Jules Bordet
[7] Willamette Valley Cancer Institute,undefined
[8] RiverBend Pavilion,undefined
[9] Exelixis,undefined
来源：
Breast Cancer Research and Treatment | 2016年 / 160卷
关键词：
Metastatic breast cancer; Cabozantinib; Vascular endothelial growth factor receptor; Progression-free survival; Overall survival; Tumor response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：305 / 312
页数：7
相关论文
共 50 条
  • [21] Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
    Hsu, Chiun
    Yang, Tsai-Sheng
    Huo, Teh-Ia
    Hsieh, Ruey-Kuen
    Yu, Chih-Wei
    Hwang, Wei-Shou
    Hsieh, Tsai-Yuan
    Huang, Wen-Tsung
    Chao, Yee
    Meng, Robin
    Cheng, Ann-Lii
    JOURNAL OF HEPATOLOGY, 2012, 56 (05) : 1097 - 1103
  • [22] Placebo-controlled, randomized, phase II study of radium-223 in metastatic hormone refractory prostate cancer (HRPC)
    Nilsson, S.
    Franzen, L.
    Tyrrel, C.
    Blom, R.
    Tennvall, J.
    Lennernas, B.
    Johannessen, D. C.
    Sokal, M.
    Parker, C.
    Bruland, O. S.
    EJC SUPPLEMENTS, 2007, 5 (04): : 295 - 295
  • [23] Everolimus (Rad001) as Treatment in Breast Cancer Patients with Bone Metastases Only - First Results of the Multi-centre, Placebo-controlled, Randomized Discontinuation Phase II RADAR Study
    Harbeck, N.
    Maass, N.
    Mundhenke, C.
    Lerchenmuller, C.
    Barinoff, J.
    Ettl, J.
    Aktas, B.
    Nekljudova, V.
    von Minckwitz, G.
    Loibl, S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S43 - S43
  • [24] ALICE: a randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer
    Kyte, J. A.
    Rossevold, A.
    Falk, R. S.
    Naume, B.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [25] ALICE: a randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer
    J. A. Kyte
    A. Røssevold
    R. S. Falk
    B. Naume
    Journal of Translational Medicine, 18
  • [26] Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury
    Casha, Steven
    Zygun, David
    McGowan, M. Dan
    Bains, Ish
    Yong, V. Wee
    Hurlbert, R. John
    BRAIN, 2012, 135 : 1224 - 1236
  • [27] GLANCE Results of a phase 2, randomized, double-blind, placebo-controlled study
    Goodman, A. D.
    Rossman, H.
    Bar-Or, A.
    Miller, A.
    Miller, D. H.
    Schmierer, K.
    Lublin, F.
    Khan, O.
    Bormann, N. M.
    Yang, M.
    Panzara, M. A.
    Sandrock, A. W.
    NEUROLOGY, 2009, 72 (09) : 806 - 812
  • [28] A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients
    Jordi Rello
    Claus-Georg Krenn
    Gottfried Locker
    Ernst Pilger
    Christian Madl
    Laura Balica
    Thierry Dugernier
    Pierre-Francois Laterre
    Herbert Spapen
    Pieter Depuydt
    Jean-Louis Vincent
    Lajos Bogár
    Zsuzsanna Szabó
    Barbara Völgyes
    Rafael Máñez
    Nahit Cakar
    Atilla Ramazanoglu
    Arzu Topeli
    Maria A. Mastruzzo
    Abel Jasovich
    Christian G. Remolif
    Liliana del Carmen Soria
    Max A. Andresen Hernandez
    Carolina Ruiz Balart
    Ildikó Krémer
    Zsolt Molnár
    Frank von Sonnenburg
    Arthur Lyons
    Michael Joannidis
    Heinz Burgmann
    Tobias Welte
    Anton Klingler
    Romana Hochreiter
    Kerstin Westritschnig
    Critical Care, 21
  • [29] A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis
    Kowdley, Kris, V
    Vuppalanchi, Raj
    Levy, Cynthia
    Floreani, Annarosa
    Andreone, Pietro
    LaRusso, Nicholas F.
    Shrestha, Roshan
    Trotter, James
    Goldberg, David
    Rushbrook, Simon
    Hirschfield, Gideon M.
    Schiano, Thomas
    Jin, Yuying
    Pencek, Richard
    MacConell, Leigh
    Shapiro, David
    Bowlus, Christopher L.
    JOURNAL OF HEPATOLOGY, 2020, 73 (01) : 94 - 101
  • [30] A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients
    Rello, Jordi
    Krenn, Claus-Georg
    Locker, Gottfried
    Pilger, Ernst
    Madl, Christian
    Balica, Laura
    Dugernier, Thierry
    Laterre, Pierre-Francois
    Spapen, Herbert
    Depuydt, Pieter
    Vincent, Jean-Louis
    Bogar, Lajos
    Szabo, Zsuzsanna
    Volgyes, Barbara
    Manez, Rafael
    Cakar, Nahit
    Ramazanoglu, Atilla
    Topeli, Arzu
    Mastruzzo, Maria A.
    Jasovich, Abel
    Remolif, Christian G.
    del Carmen Soria, Liliana
    Andresen Hernandez, Max A.
    Ruiz Balart, Carolina
    Kremer, Ildiko
    Molnar, Zsolt
    von Sonnenburg, Frank
    Lyons, Arthur
    Joannidis, Michael
    Burgmann, Heinz
    Welte, Tobias
    Klingler, Anton
    Hochreiter, Romana
    Westritschnig, Kerstin
    CRITICAL CARE, 2017, 21
12345